Healthcare provider profile · identity verified

Troy Renaud, D.O.

Family Practice · LA PORTE CITY, IA · NPI 1164478467

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	469	104
Levothyroxine Sodium	Levothyroxine Sodium	459	88
Amlodipine Besylate	Amlodipine Besylate	426	96
Furosemide	Furosemide	299	63
Lisinopril	Lisinopril	263	58
Rosuvastatin Calcium	Rosuvastatin Calcium	256	67
Metoprolol Succinate	Metoprolol Succinate	250	59
Omeprazole	Omeprazole	248	64
Pantoprazole Sodium	Pantoprazole Sodium	222	47
Losartan Potassium	Losartan Potassium	218	52
Potassium Chloride	Potassium Chloride	207	38
Tramadol Hcl	Tramadol Hcl	206	48
Gabapentin	Gabapentin	175	39
Warfarin Sodium	Warfarin Sodium	168	suppressed
Metformin Hcl Er	Metformin Hcl	161	34
Sertraline Hcl	Sertraline Hcl	156	34
Meloxicam	Meloxicam	148	40
Hydrochlorothiazide	Hydrochlorothiazide	146	38
Clopidogrel	Clopidogrel Bisulfate	138	21
Tamsulosin Hcl	Tamsulosin Hcl	116	32
Metoprolol Tartrate	Metoprolol Tartrate	103	27
Eliquis	Apixaban	100	17
Pravastatin Sodium	Pravastatin Sodium	94	21
Escitalopram Oxalate	Escitalopram Oxalate	92	14
Glipizide	Glipizide	90	18
Bumetanide	Bumetanide	81	13
Mirtazapine	Mirtazapine	81	14
Donepezil Hcl	Donepezil Hcl	78	14
Lorazepam	Lorazepam	77	31
Trazodone Hcl	Trazodone Hcl	75	16
Carvedilol	Carvedilol	74	14
Diclofenac Sodium	Diclofenac Sodium	74	12
Quetiapine Fumarate	Quetiapine Fumarate	73	suppressed
Myrbetriq	Mirabegron	72	suppressed
Alendronate Sodium	Alendronate Sodium	69	17
Zolpidem Tartrate	Zolpidem Tartrate	69	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	68	36
Atenolol	Atenolol	64	13
Ezetimibe	Ezetimibe	64	14
Oxybutynin Chloride Er	Oxybutynin Chloride	64	21
Ozempic	Semaglutide	63	suppressed
Jardiance	Empagliflozin	60	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	11
Metformin Hcl	Metformin Hcl	57	12
Allopurinol	Allopurinol	56	17
Spironolactone	Spironolactone	56	12
Duloxetine Hcl	Duloxetine Hcl	55	suppressed
Prednisone	Prednisone	55	44
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	53	12
Baclofen	Baclofen	53	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	20
Oxycodone Hcl	Oxycodone Hcl	53	16
Buspirone Hcl	Buspirone Hcl	52	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	52	21
Montelukast Sodium	Montelukast Sodium	50	suppressed
Pregabalin	Pregabalin	49	suppressed
Glipizide Er	Glipizide	47	suppressed
Famotidine	Famotidine	46	suppressed
Irbesartan	Irbesartan	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Alprazolam	Alprazolam	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	39	31
Finasteride	Finasteride	39	suppressed
Clonazepam	Clonazepam	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	16
Latanoprost	Latanoprost	38	suppressed
Morphine Sulfate Er	Morphine Sulfate	38	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Ipratropium Bromide	Ipratropium Bromide	37	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	37	suppressed
Timolol Maleate	Timolol Maleate	37	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Glimepiride	Glimepiride	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	11
Torsemide	Torsemide	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	14
Levetiracetam	Levetiracetam	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Simvastatin	Simvastatin	30	suppressed
Azithromycin	Azithromycin	29	25
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	28	28
Gemfibrozil	Gemfibrozil	28	suppressed
Loperamide	Loperamide Hcl	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Temazepam	Temazepam	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Cholestyramine	Cholestyramine (With Sugar)	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	12
Verapamil Er	Verapamil Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Levofloxacin	Levofloxacin	20	15
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Digoxin	Digoxin	18	suppressed
Haloperidol	Haloperidol	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Ondansetron Odt	Ondansetron	17	14
Diazepam	Diazepam	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	11
Enalapril Maleate	Enalapril Maleate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Cefdinir	Cefdinir	15	12
Divalproex Sodium	Divalproex Sodium	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	12
Trulicity	Dulaglutide	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	11
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Cephalexin	Cephalexin	13	13
Haloperidol Decanoate	Haloperidol Decanoate	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Alphagan P	Brimonidine Tartrate	12	suppressed
Anastrozole	Anastrozole	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Methimazole	Methimazole	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Cefuroxime	Cefuroxime Axetil	11	11
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	11
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error